Nicotinamide N‐methyltransferase ameliorates renal fibrosis by its metabolite 1‐methylnicotinamide inhibiting the TGF‐β1/Smad3 pathway. Issue 3 (2nd February 2022)

• Record Type: Journal Article
• Authors: Zhang, Wenying; Rong, Guang; Gu, Jinge; Fan, Cuiling; Guo, Tingting; Jiang, Tingting; Deng, Weiqian; Xie, Jiayu; Su, Zhihua; Yu, Qimin; Mai, Jingyi; Zheng, Rinan; Chen, Xingling; Tang, Xun; Zhang, Jun
• Is Part Of: FASEB journal. Volume 36:Issue 3(2022)
• Page Start: n/a
• Page End: n/a
• Publication Date: 2022-02-02
• Subjects: 1‐methylnicotinamide (MNAM) -- chronic kidney disease (CKD) -- nicotinamide N‐methyltransferase (NNMT) -- TGF‐β1/Smad3 -- tubulointerstitial fibrosis (TIF); Biology -- Periodicals; Biology, Experimental -- Periodicals; 570
• DOI: 10.1096/fj.202100913RRR
• Languages: English
• ISSNs: 0892-6638

Abstract

Abstract: Chronic kidney disease (CKD), a disease involving damage to the kidney structure and function, is a global public health problem. Tubulointerstitial fibrosis (TIF) is both an inevitable pathological change in individuals with CKD and a driving force in the progression of renal fibrosis. Nicotinamide N‐methyltransferase (NNMT) and its metabolite 1‐methylnicotinamide (MNAM) have been shown to protect against lipotoxicity‐induced kidney tubular injury. However, the biological roles of NNMT and MNAM in regulating TIF remain elusive. This study aimed to investigate the protective effect of NNMT and MNAM on TIF and the mechanisms involved. We explored the functions and mechanisms of NNMT and MNAM in TIF, as well as the interaction between NNMT and MNAM, using unilateral ureteral obstruction (UUO) mice and cultured mouse tubular epithelial cells (mTECs) stimulated with transforming growth factor‐β1 (TGF‐β1). Several important findings were obtained as follows: (1) NNMT expression was upregulated in the kidneys of UUO mice and TGF‐β1‐induced mTECs, and this upregulation was proposed to be a protective compensatory response to TIF. (2) MNAM was a potentially effective antifibrotic and anti‐inflammatory medication in UUO mice. (3) The antifibrotic effect of NNMT overexpression was exerted by increasing the concentration of MNAM. (4) The renoprotective role of MNAM depended on the selective blockade of the interaction of Smad3 with TGFβ receptor I. Overall, our study shows that NNMT is involved in the development and progression of CKD and that its metabolite MNAM may be a novel inhibitor of the TGF‐β1/Smad3 pathway with great therapeutic potential for CKD.